Why is a diabetic drug that was approved for use in developed nations over seven years ago still not legally available in Trinidad and Tobago?At a Joint Select Committee (JSC) ...
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...
For the first time in 30 years, the Food and Drug Administration is updating its claim on what food products can use the word ...
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
Websites that sell compounded glucagon-like peptide-1 receptor agonists often partially inform or misinform consumers.
There were unforgiveable shortcomings in management, which included critical information not reaching senior officials as ...